Cent Eur J Public Health 2020, 28(1):59-64 | DOI: 10.21101/cejph.a4993

Lung cancer incidence and mortality in Split-Dalmatia County, 2003-2012

Ivana Marasović Šušnjara
Teaching Public Health Institutes of Split and Dalmatian County, Split, Croatia

Objective: The aim of the study was to analyze indicators on lung cancer (C33-C34, ICD-10) in Split-Dalmatia County in the period 2003-2012.

Methods: Data on lung cancer occurrence for the period 2003-2012 were obtained from the Croatian National Cancer Registry, while mortality data were obtained from electronic database of the Teaching Public Health Institute of Split-Dalmatia County. Croatian census 2011 and population estimates of the Central Bureau of Statistics of the Republic of Croatia were used to calculate the indicators. Results are presented as absolute numbers, shares (%), specific rates per 100,000 population, age-standardized rate (standard European population).

Results: There were 2,804 registered patients with lung cancer in the period 2003-2012 in Split-Dalmatia County - 2,179 men (77.71%) and 625 women (22.29%); 2,737 people died from lung cancer in the same period - 2,117 men (77.35%) and 620 women (22.65%). Specific rates of incidence and mortality rates were four times higher among men than among women. From 2003 to 2012, the rate of incidence among men showed a significant decrease, while among women there were no significant changes of incidence and mortality.

Conclusions: According to the indicators of incidence and mortality of lung cancer in Split-Dalmatia County, this malignant neoplasm should occupy a high place within County public health priorities measures of prevention programme, targeting risk factors responsible for their formation.

Klíčová slova: epidemiology, incidence, mortality, lung carcinoma, Split-Dalmatia County

Vloženo: 29. listopad 2016; Revidováno: 20. prosinec 2019; Přijato: 20. prosinec 2019; Zveřejněno: 30. březen 2020  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marasović Šušnjara I. Lung cancer incidence and mortality in Split-Dalmatia County, 2003-2012. Cent Eur J Public Health. 2020;28(1):59-64. doi: 10.21101/cejph.a4993. PubMed PMID: 32228819.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Zobrazit celý článek

    Reference

    1. World Health Organization. Atlas of health in Europe. Copenhagen: WHO; 2008.
    2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403. Přejít k původnímu zdroji... Přejít na PubMed...
    3. Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston (USA): Harvard School of Public Health; 1996.
    4. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol. 1999;10(S5):S3-6. Přejít k původnímu zdroji... Přejít na PubMed...
    5. Vrdoljak E. Cancer in Croatia: where do we stand and how to move forward? Croat Med J. 2012;53(2):91-2. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. Přejít k původnímu zdroji... Přejít na PubMed...
    7. Peto R, Lopez AD, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2000 [Internet]. 2006 [cited 2016 March 18]. Available from: https://www.deathsfromsmoking.net/publications.html.
    8. Zatonski WA, Manczuk M, Powels J, Negri E. Convergence of male and female lung cancer mortality at younger ages in the European Union and Russia. Eur J Public Health. 2007;17(5):450-4. Přejít k původnímu zdroji... Přejít na PubMed...
    9. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581-92. Přejít k původnímu zdroji... Přejít na PubMed...
    10. Croatian Institute of Public Health. Cancer incidence in Croatia, 2012. Bulletin No 37 [Internet]. Zagreb: Croatian Institute of Public Health; 2014 [cited 2016 March 18]. Available from: http://www.hzjz.hr/wp-content/uploads/2013/11/Bilten-2012_final.pdf. (In Croatian.)
    11. World Health Organization. International statistical classification of diseases and related health problems. Geneva: WHO;1993.
    12. Cancer incidence in five continents, Volume VIII. IARC Sci Publ. 2002;(155):1-831.
    13. Rubin SA. Lung cancer: past, present, and future. J Thorac Imaging. 1991;7(1):1-8. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Krewski D, Lubin JH, Zielinski JM, Alavanja M, Catalan VS, Field RW, et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology. 2005;16(2):137-45. Přejít k původnímu zdroji... Přejít na PubMed...
    15. Alberg AJ, Brock MV, Ford JG, Samet JM, Spivack SD. Epidemiology of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e1S-e29S. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Ćurin K, Šarić M, Strnad M. Incidence of malignant mesothelioma in coastal and continental Croatia: epidemiological study. Croat Med J. 2002;43(4):498-502. Přejít na PubMed...
    17. De Grot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res. 2018;7(3):220-33. Přejít k původnímu zdroji... Přejít na PubMed...
    18. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer:epidemiology, etiology, and prevention. Clin Chest Med. 2011;32(4):605-44. Přejít k původnímu zdroji... Přejít na PubMed...
    19. Lissowska J, Foretova L, Dabek J, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, et al. Family history and lung cancer risk: international multicentre case-control study in Eastern and Central Europe and meta-analyses. Cancer Causes Control. 2010;21(7):1091-104. Přejít k původnímu zdroji... Přejít na PubMed...
    20. Danaei G, Vander HS, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioral and environmental risk factors. Lancet. 2005;366(9499):1784-93. Přejít k původnímu zdroji... Přejít na PubMed...
    21. Janssen-Heijnen MLG, Coebergh JWW. The changing epidemiology of lung cancer in Europe. Lung Cancer. 2003;41(3):245-58. Přejít k původnímu zdroji... Přejít na PubMed...
    22. Marasovic Šušnjara I. Smoking behavior and exposure to tobacco smoke in Split-Dalmatia County. Eur J Public Health. 2019;29(4):ckz186.436. doi:10.1093/eurpub/ckz186.436. Přejít k původnímu zdroji...
    23. Organisation for Economic Co-operation and Development; European Observatory on Health Systems and Policies. Croatia: Country Health Profile 2019. State of Health in the EU. Paris: OECD Publishing; 2019.
    24. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. Přejít k původnímu zdroji... Přejít na PubMed...
    25. Bray F, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer. 2010;126(6):1454-66. Přejít k původnímu zdroji... Přejít na PubMed...
    26. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356-87. Přejít k původnímu zdroji... Přejít na PubMed...
    27. Doll R, Peto R, Wheatly K, Grey R, Sutherland I. Mortality in relation to smoking: 40 years' observationson male British doctors. BMJ. 1994;309:901. doi: 10.1136/bmj.309.6959.901. Přejít k původnímu zdroji... Přejít na PubMed...
    28. de Jong WK, Schaapveld M, Blaauwgeers, Groen HJM. Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours. Thorax. 2008;63(12):1096-102. Přejít k původnímu zdroji... Přejít na PubMed...
    29. Ministry of Health of the Republic of Croatia. National Program for the Screening and Early Detection of Lung Cancer 2019-2023 [Internet]. Zagreb; 2019 [cited 2016 March 18]. Available from: https://zdravstvo.gov.hr/izvjesce-o-provedenom-savjetovanju-o-nacrtu-nacionalnog-programa-za-probir-i-rano-otkrivanje-raka-pluca-2019-2023/3579. (In Croatian.)
    30. Zheng H, Zeltsman M, Zauderer MG, Eguchi T, Vaghjiani RG, Adusumilli PS. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy. Immunotherapy. 2017;9(11):913-27. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah